Bird Flu Cases In US: Could It Trigger The Next Global Pandemic?
The specter of bird flu, or Avian Influenza A (H5N1), is once again looming, this time in a more ominous leap from animals to humans. As the threat level at the moment remains low, the experts are watching closely its new species and regional interventions, raising alarms about its potential to mutate into a more dangerous form. With cases flying under the radar largely, it becomes crucial to understand the trajectory of the virus, its potential risks, and preparedness challenges.
The H5N1 bird flu has evolved from being an avian problem to infecting mammals and, occasionally, humans. Recent outbreaks have affected poultry, dairy cows, and humans in several U.S. states, including California, Colorado, Michigan, Missouri, Texas, and Washington. Infections among farmworkers—mostly those milking cows or cleaning barns—have been reported, with symptoms such as eye redness, fever, sneezing, and sore throat.
Testing of 115 dairy workers from Michigan and Colorado revealed that 7% had antibodies against the H5N1 virus, indicating previous exposure. Half of these individuals reported no illness, suggesting that some infections may result in mild or even asymptomatic cases.
The behavior of H5N1 also raised red flags globally. In Cambodia, a hybrid strain between two subtypes of the virus has emerged, with at least three deaths and displaying mutations that enhance airborne transmission among mammals. These developments underscore the virus's ability to adapt, making vigilant monitoring critical.
Several U.S. federal agencies are working in tandem to address the outbreak:
-The USDA leads from the animal health side by coordinating with the FDA and CDC.
-The FDA ensures safety for milk, dairy products, and feed intended for animals in order to safeguard public health.
-The CDC tracks human infections, tests potential cases, and tracks virus movement.
Despite these efforts, challenges remain. Testing gaps, limited surveillance in some states, and flaws in diagnostic tools mean many cases may go undetected, leaving communities vulnerable.
While human-to-human transmission of H5N1 has not been documented, the possibility remains a primary concern. Historical data paints a grim picture: since the virus's discovery in 1997, over 900 reported human cases have occurred globally, with a mortality rate exceeding 50%. Cambodia recently reported ten cases, including two fatalities, attributed to a more virulent strain.
If H5N1 mutates further to attain sustained human-to-human transmission, it will unleash a pandemic of catastrophic proportions. The US federal government has started the process of vaccine stockpiling, but the present level of supply is alarmingly grossly inadequate.
The United States has less than five million doses of H5N1 vaccines, which would be enough to cover only 2% of the population. Manufacturing contracts also have been signed to produce an additional 10 million syringes by 2025, though this timeline may be too slow in the face of a rapidly evolving virus.
The technology behind these vaccines is also antiquated. Most are produced in a slow and inflexible, century-old egg-based process. No licensed mRNA-based flu vaccine—a technology that proved so valuable during the COVID-19 pandemic—is available to add to this preparedness.
According to an immunologist, Dr. Vasso Apostolopoulos, genetic makeup could influence virulence for H5N1. Mutations in genes critical for such functions as hemagglutinin, helping viruses get inside the cells, and another that helps in enhancing replication, have been discovered recently. This may mean that genetic mutations may further enhance its capacity to induce severe disease.
The similarity between H5N1 and early COVID-19 is unnerving. Like SARS-CoV-2, H5N1 can quietly spread until a tipping point is reached. The world saw how quickly a virus could immobilize societies before vaccines were widespread. Still, current preparedness for a bird flu pandemic is still woefully insufficient.
It took almost a year to bring forward the first COVID-19 vaccines, in which millions lost their lives due to the virus. Experts believe that H5N1 will not present humanity with the flexibility to adapt slowly. The delayed response of the world towards the spread of a future H5N1 pandemic may be devastatingly slow unless advanced vaccine technologies are prepared proactively and investment in it is made.
To reduce the spread of H5N1, robust responses are required:
1. Public health agencies should increase testing for H5N1 in humans and animals, especially in high-risk environments like farms.
2. Accelerating the development and stockpiling of mRNA-based vaccines could provide a faster, more adaptive response.
3. Countries must share data, resources, and expertise to monitor and contain the virus.
4. Protective measures in case of exposure to infected animals for farmworkers are essential, such as wearing personal protective equipment and health checkup on a regular basis. H5N1 bird flu is a stark reminder that the line between preparedness and vulnerability is thin.
The risk at this moment is low, but the mutation and the historical lethality it holds require a proactive attitude. The lessons from COVID-19 highlight the price paid for underestimation of a virus's potency. The next pandemic will not be if, but when. Whether we rise to the challenge or repeat past mistakes will therefore define the impact of H5N1 on global health.
Credits: Canva
October is Breast Cancer Awareness Month, making it the perfect time to focus on habits that can help protect your health. While no single food can guarantee prevention, research shows that certain nutrients and antioxidants found in everyday foods may play a role in reducing the risk of breast cancer. For women, especially those with risk factors, incorporating these foods into your diet can be a meaningful step toward prevention.
Understanding Breast Cancer
Breast cancer occurs when breast cells start to grow abnormally and form tumours. If these tumours are not treated, they can spread to other parts of the body and become life-threatening. According to the World Health Organization (WHO), this disease claimed an estimated 670,000 lives worldwide in 2022. In India, breast cancer is also increasing, with one in 28 women now at risk. This makes it all the more important to understand ways to lower risk through lifestyle and dietary choices.
Nutritionist and weight loss specialist Leema Mahajan took to her Instagram to highlight the power of food in breast cancer prevention. She emphasizes starting early: “Introducing these foods into your diet from a young age can help reduce your chances of developing this disease later in life.” Mahajan identifies six key foods backed by research for their potential protective benefits.
Pomegranates are rich in compounds called ellagitannins, which studies suggest may help slow down the growth of cancer cells and limit estrogen-driven tumour development. Mahajan recommends enjoying one cup of fresh pomegranate each day. “Fresh pomegranate seeds can support your body’s fight against abnormal cell growth. It’s simple, delicious, and effective,” she says.
2. Cruciferous Vegetables
Vegetables like broccoli, cauliflower, cabbage, and Brussels sprouts belong to the cruciferous family, known for their cancer-fighting properties. These vegetables contain sulforaphane, a compound that aids the liver in breaking down harmful estrogen by-products and may help prevent tumour formation. Mahajan advises, “Include cruciferous vegetables in your meals three to four times a week. You can eat them raw in salads or lightly steamed to retain their nutrients.”
Berries such as blueberries, strawberries, and raspberries are packed with antioxidants, particularly anthocyanins, which help combat cell damage and inflammation. Adding a handful of berries to your breakfast or as a snack is a tasty and nutritious way to support your body’s natural defenses.
4. Fatty Fish
Omega-3 fatty acids found in salmon, mackerel, and sardines may have anti-inflammatory properties that reduce cancer risk. Including fatty fish two to three times a week can support overall health and may help maintain hormone balance.
Green tea contains polyphenols, which have been shown to slow cancer cell growth in laboratory studies. Drinking two to three cups daily can be a simple, comforting habit with potential protective benefits.
Tomatoes are rich in lycopene, an antioxidant linked to lower cancer risk. Cooking tomatoes, such as in sauces or soups, makes lycopene more easily absorbed by the body.
Incorporating these foods into your daily meals isn’t just about prevention, it’s also about building a sustainable, healthful lifestyle. While diet alone cannot prevent breast cancer, combining these nutritious foods with regular exercise, adequate sleep, and routine medical screenings can strengthen overall health and reduce long-term risk.
Eating with awareness, enjoying colorful fruits and vegetables, and making consistent, balanced choices can empower women to take charge of their health, one meal at a time.
(Credit-Canva)
New research suggests that the common way doctors measure a healthy weight, called Body Mass Index (BMI), may not be the best tool for figuring out a person's risk for cancer. Instead, the study found that where a person carries their extra fat, especially fat around the stomach, is a much more important clue.
A new study published in the Journal of the National Cancer Institute, found that belly fat plays a big role, not just in our general health but also in cancer. However, how does fat around your mid-section define this?
For many years, doctors have used BMI (which is calculated from your height and weight) to see if someone is overweight or obese and then use that status to estimate their risk for various cancers. However, this new study found that relying only on BMI is too basic. The research suggests that the location of extra fat on your body might be just as important, if not more so, in deciding whether your risk of developing several types of cancer goes up or down.
The study used advanced methods to look at the relationship between fat in five different areas of the body and the risk for 12 common cancers linked to being overweight. The clearest and most alarming finding was that fat around the abdomen (belly fat) was the most dangerous type of fat:
Belly fat was directly linked to a higher chance of developing three specific cancers: endometrial cancer (of the uterus), esophageal cancer (in the food pipe), and liver cancer.
Doctors pointed out that carrying fat in the center of your body is already known to cause problems like diabetes and heart disease. They believe this is because central fat causes a lot of inflammation inside the body, and this inflammation is what can actually encourage cancer to grow.
While fat around the stomach was dangerous, the researchers made a surprising discovery about lower body fat. They found that fat carried in the buttocks and thighs actually seemed to help protect against cancer. This fat was linked to a reduced risk of both breast cancer and a type of brain tumor called meningioma. This unexpected result has led some experts to think that the fat cells in the lower body might produce helpful hormones that fight against cancer.
This research strongly confirms that doctors shouldn't just rely on the single BMI number. As one cancer doctor noted, BMI is a "quick and dirty" measurement that only gives a very basic picture of your health; the location of excess fat matters much more. Scientists believe fat increases cancer risk in a few ways, including:
The study concludes that future health plans, both for treating obesity and preventing cancer, should focus on measuring and managing where fat is distributed rather than just focusing on overall weight. While losing weight is still beneficial, the body part where the fat is concentrated is a powerful indicator of risk.
(Credit-Canva)
There are many aspects of an organ donation, not just the need for an organ, but also how compatible it is in terms of blood type. The reason why this is important is because of components known as antigens. The recipient's own body can destroy the new organ if the donated organ has different antigens. However, scientists may have found a way to surpass this issue.
A major scientific breakthrough has occurred: scientists successfully changed the blood type of a donated kidney using a special enzyme and then transplanted it into a patient. This is the first procedure of its kind. Right now, a patient can only receive an organ if the donor has a compatible blood type. If the types don't match, the patient's immune system will immediately produce antibodies or immune soldiers to attack and destroy the foreign organ.
The research team from Canada and China found a special enzyme that can remove the Type A antigens from an organ. Antigens are the markers on blood cells (and organs) that determine blood type. By removing the Type A markers, the enzyme essentially converts Type A blood into Type O blood.
Type O is considered the "universal" donor type because anyone can receive it. In this first test, the converted Type O kidney was transplanted into a 68-year-old patient. Although the kidney eventually showed signs of rejection after two days, it was able to function and produce urine for six days, proving the concept works.
If doctors can successfully change the blood type of a donor organ, the current limits on transplants would largely disappear, creating enormous benefits for patients.
Without the need to match blood types, doctors wouldn't have to wait for an organ that is both a good match and the correct blood type. Instead, they could focus only on other factors important for the transplant's long-term success. By removing the blood type obstacle, this technology would allow for faster matching and quicker surgeries, which will dramatically reduce the painfully long waiting lists that patients currently face.
Without the restriction of matching blood types, doctors wouldn't have to wait for an organ that is both a good match and the correct blood type. Instead, they could focus on other crucial factors, like matching proteins and tissues that are important for the long-term success of the transplant. By eliminating the blood type hurdle, this technology would allow for faster matching and quicker surgeries, drastically reducing the painfully long wait lists that patients currently face for life-saving organs.
This new approach of treating the donor organ instead of the patient is a major advancement. Right now, to perform a blood-type-mismatched transplant, the patient has to get intense treatments beforehand to severely weaken their immune system. These treatments are risky because they significantly increase the patient's vulnerability to severe infections.
Furthermore, for deceased donor organs—which must be used very quickly—there simply isn't enough time to safely administer these pre-treatments. By converting the organ outside the body, doctors can avoid this high-risk step for the recipient, making the transplant safer and much more feasible for emergency cases.
This successful first attempt proves the enzyme-conversion technique works, but it's just the beginning. The scientists now need to conduct more studies on both brain-dead and living patients. Their main goal is to figure out the best way to adjust the treatment so that the converted organ can function successfully for a long period, ultimately allowing this revolutionary technique to be used in hospitals everywhere.
© 2024 Bennett, Coleman & Company Limited